TY - JOUR
T1 - Clinical characteristics and analysis of prognostic factors in methicillin-resistant Staphylococcus aureus endocarditis
T2 - A retrospective multicenter study in Japan
AU - Mitsutake, Kotaro
AU - Shinya, Natsuki
AU - Seki, Masafumi
AU - Ohara, Takahiro
AU - Uemura, Kohei
AU - Fukunaga, Masato
AU - Sakai, Jun
AU - Nagao, Miki
AU - Sata, Makoto
AU - Hamada, Yohei
AU - Kawasuji, Hitoshi
AU - Yamamoto, Yoshihiro
AU - Nakamatsu, Masashi
AU - Koizumi, Yusuke
AU - Mikamo, Hiroshige
AU - Ukimura, Akira
AU - Aoyagi, Tetsuji
AU - Sawai, Toyomitsu
AU - Tanaka, Takeshi
AU - Izumikawa, Koichi
AU - Takayama, Yoko
AU - Nakamura, Kiwamu
AU - Kanemitsu, Keiji
AU - Tokimatsu, Issei
AU - Nakajima, Kazuhiko
AU - Akine, Dai
N1 - Publisher Copyright:
© 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control
PY - 2024/12
Y1 - 2024/12
N2 - Background: Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients with MRSA-IE in Japan and identify the factors associated with prognosis. Methods: This retrospective study included patients with a confirmed diagnosis of IE caused by MRSA, between January 2015 and April 2019. Results: A total of 65 patients from 19 centers were included, with a mean age of 67 years and 26 % were female. Fifty percent of the patients with IE were had nosocomial infections and 25 % had prosthetic valve involvement. The most common comorbidities were hemodialysis (20 %) and diabetes (20 %). Congestive heart failure was present in 86 % of patients (NYHA class I, II: 48 %; III, IV: 38 %). The 30-day and in-hospital mortality rates were 29 % and 46 %, respectively. Multi-organ failure was the primary cause of death, accounting for 43 % of all causes of death. Prognostic factors for in-hospital mortality were age, disseminated intravascular coagulation, daptomycin and/or linezolid as initial antibiotic therapy, and surgery. Surgical treatment was associated with a lower mortality rate (odds ratio [OR], 0.026; 95 % confidence interval [CI], 0.002–0.382; p = 0.008 for 30-day mortality and OR, 0.130; 95 % CI; 0.029–0.584; p = 0.008 for in-hospital mortality). Conclusion: Mortality due to MRSA-IE remains high. Surgical treatment is a significant prognostic predictor of MRSA-IE.
AB - Background: Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients with MRSA-IE in Japan and identify the factors associated with prognosis. Methods: This retrospective study included patients with a confirmed diagnosis of IE caused by MRSA, between January 2015 and April 2019. Results: A total of 65 patients from 19 centers were included, with a mean age of 67 years and 26 % were female. Fifty percent of the patients with IE were had nosocomial infections and 25 % had prosthetic valve involvement. The most common comorbidities were hemodialysis (20 %) and diabetes (20 %). Congestive heart failure was present in 86 % of patients (NYHA class I, II: 48 %; III, IV: 38 %). The 30-day and in-hospital mortality rates were 29 % and 46 %, respectively. Multi-organ failure was the primary cause of death, accounting for 43 % of all causes of death. Prognostic factors for in-hospital mortality were age, disseminated intravascular coagulation, daptomycin and/or linezolid as initial antibiotic therapy, and surgery. Surgical treatment was associated with a lower mortality rate (odds ratio [OR], 0.026; 95 % confidence interval [CI], 0.002–0.382; p = 0.008 for 30-day mortality and OR, 0.130; 95 % CI; 0.029–0.584; p = 0.008 for in-hospital mortality). Conclusion: Mortality due to MRSA-IE remains high. Surgical treatment is a significant prognostic predictor of MRSA-IE.
KW - Endocarditis
KW - Methicillin-resistant Staphylococcus aureus
KW - Multi-organ failure
KW - Prognosis
KW - Surgical treatment
UR - http://www.scopus.com/inward/record.url?scp=85196014492&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2024.06.002
DO - 10.1016/j.jiac.2024.06.002
M3 - 学術論文
C2 - 38876203
AN - SCOPUS:85196014492
SN - 1341-321X
VL - 30
SP - 1259
EP - 1265
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 12
ER -